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ABSTRACT 
 
Aims: Pseudomonas aeruginosa is an opportunistic pathogen that still develops life threatening infections in patients 
with immunological system defects like burns. The major problem with this organism is the ability to persist during 
infections due to its high rate of resistance to many drugs. This study was designed to evaluate the prevalence and drug 
susceptibility profile of Pseudomonas aeruginosa in patients admitted to a burn unit in a tertiary health facility.  
Methodology and Result: From 80 selected patients, appropriate clinical specimens from burn sites were collected and 
processed for the isolation and identification of Pseudomonas aeruginosa.. Also, 78 surveillance samples from various 
environmental  sites  and  hands  impressions  of  nursing  staff  in  the  burn  unit  were  cultured  for  the  isolation  of 
Pseudomonas  aeruginosa.  Drug  susceptibility  profile  showed  high  resistance  for  ceftazidime  (40.7%)  ciprofloxacin 
(13.1%)  and  piperacillin  (34.6%);  furthermore,  low  resistance  for  some  antibiotics  like  imipenem  (17.5%) 
pipereracillin/tazobactam  (12.3%)  and  aztreonam  (16%)  were  obtained.  In  addition,  8  multiresistant  Pseudomonas 
aeruginosa (MRPA) isolates were recovered from clinical specimens and from environmental samples. 
Conclusion, significance  and impact of study:  Evidence of high prevalence of clinical and environmental MRPA 
reported in this study provides the rationale for strict enforcement of infection prevention protocol to minimize cross 
transmission of bacterial pathogens in hospital burn units and consequent disease burden arising from MRPA. 
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INTRODUCTION 
 
Infection in the burn unit has been under intense study 
over the past few decades (Gikas et al., 2000; Pruitt et al., 
1998).  Immunucompromised or critically ill patients are at 
high risk of getting the hospital acquired infections.   
Bacterial infections following severe burn injuries can be 
most simplistically attributed to extensive breaches in the 
skin  barrier.  The  fact  that  Pseudomonas  aeruginosa 
occurs  so  commonly  in  the  environment  makes  it 
extremely  likely that an individual suffering severe burns 
will  be  challenged  with  this  micro-organism  before  the 
burns can heal (Erol et al., 2004).  Since this bacterium is 
naturally  resistant  to  many  drugs  and  is  able  to  get 
resistance to all effective antimicrobials, the infection with 
this  organism  is  particularly  problematic  condition  for 
patients. 
  Burn units are known to harbour multidrug resistant 
(MDR)  Pseudomonas  aeruginosa  that  can  serve  as 
source of infection (Rossolini et al., 2005).  Apart from the 
inanimate  hospital  environment,bacterial  flora  is  also 
carried  into  a  hospital  by  the  patient  and  can  be  an 
important source of infection for the same individuals after 
burn  injuries.    The  worst  scenario  occurs  when  such 
strain  cross  contaminate  other  burn  victims  and  can 
persist throughout several course of antibiotic treatment. 
In an outbreak of P. aeruginosa in a hospital, including a 
medical/surgical  unit, a  stepdown  and  a  transplant  unit, 
more environmental strains of the bacteria was recovered 
from sink drains and faucet heads than from equipment 
such  as  respiratory  equipment,  intravenous  monitors, 
dispensing machines, ice machines, fluid dispensers and 
scissor hooks. (Hota et al., 2009).  
  In  another  study  that  reviewed  a  6-year  antibiotic 
susceptibility  record  to  assess  the  prevalence  of  MDR 
isolates  at  a  US  Army  burn  center,  Acinetobacter 
baumannii  (22%)  was  found  to  be  most  prevalent 
organism  recovered,  followed  by  Pseudomonas 
aeruginosa (20%) (Keen et al., 2010). P. aeruginosa, was 
also found to be resistant to all 4 classes of antibiotics 
tested in the study, including colistin. 
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  Antibiotic  susceptibility  test  is  therefore  imperative 
as it guides the selection of an effective regimen of the 
treatment of Pseudomonas aeruginosa infections.  Data 
from antibiograms are most useful when initiating empiric 
therapy  or  when  tracking  antimicrobial  resistance  over 
time within a hospital or health care system (Agnihotri et 
al., 2004).  Accordingly our work sought to determine the 
profile  of  drug  susceptibility  and  colonization  routes  of 
Pseudomonas aeruginosa isolated from burn injuries with 
a  view  to  making  informed  decisions  on  the  choice  of 
effective clinical management of the disease burden. 
 
MATERIALS AND METHODS 
 
The  University  of  Calabar  Teaching  Hospital  (UCTH)  is 
one of the many referral centres in South-South Nigeria, 
for  patients  with  severe  burn  injuries.    Patients  were 
hospitalized  in  the  burn  unit  following  different  types  of 
burn injuries; gasoline (n = 15), oil (n=18), boiling water 
(n= 44), flame (n=6) acid (n=3).  The age range of patients 
was  classified  as  follows:  under  15  (n=46),  15  to  40 
(n=20), above 40 (n=14).There were altogether 49 male 
and 31 female patients.  Clinical samples included burn 
wounds  swabs;  environmental  samples  (78)  were  water 
from  faucets,  swabs  from  sinks,  floors,  door  handles, 
dressing  trolleys,  hand  impressions  of  staff,  antiseptics 
and  other  areas  with  potentials  for  cross  contamination 
though out the burn unit. 
  Samples were collected and processed on a weekly 
basis for a period of 3 months, June to August, 2009 after 
due  ethical  considerations.    Altogether  158  samples 
(Clinical  and  environmental)  were  obtained.    Samples 
were  cultured  on  Mueller–Hinton  agar  at  37  °C  for  34 
hours  by  the  disk  diffusion  method  described  by  Kirby-
Bauer  (Bauer  et  al.,  1966).  Pseudomonas  aeruginosa 
isolates  were  identified  to  specie  level  using  standard 
laboratory procedures (Kiska, et al., 2003). 
Drug  susceptibility  tests  were  done  for  all  isolates  by 
Bauer–Kirby  agar  diffusion  method  for  the  following 
antimicrobial agents amikacin  (30 µg), aztreonam (10 µg) 
cefotaxime  (10 µg) ceftazidime (10 µg) ceftizoxime (10 
µg) ciprofloxacin (5 µg ) gentamicin (10 µg) imipenem (10 
µg) Kanamycin (30 µg) meropenem (10 µg)  piperacillin 
(100 µg) piperacillin/tazobactam (100/10 µg) polymyixin β 
(300  units)    (Mast  diagnostics,  Merseyside,  UK).    CLSI 
breakpoints were used to determine susceptibility (CLSI, 
2006).    Quality  control  was  carried  out  using  standard 
strain of Pseudomonas aeruginosa (ATCC 12278). Multi-
drug  resistant  (MDR)  Pseudomonas  aeruginosa  isolates 
were those resistant to ceftazidime and at least 3 of the 
following antibiotics, amikacin, aztreonam,  ciprofloxacin, 
gentamicin, imipenem, piperacillin and aminoglycoside. 
RESULTS 
 
Out of a total number of 86 patients admitted in the Burn 
Unit  (BU),  80  with  serious  burn  injuries  (90%)  were 
included in this study; 46 (60%) were under 15, 20 (25%) 
between 15 and 40 yr while 14  (17.5%) were above 40; 
49  (61.3%)  were  male  31  (38.8%)  were  female.    The 
median length of burn unit stay was 29 days. 
  During  the  course  of  the  surveillance  study, 
environmental  samples  (78)  revealed  that  13  were 
positive for Pseudomonas aeruginosa. Of these 8 (61.5%) 
isolates  came  from  hand impression cultures  of  nursing 
staff, 2 (15.4%) from air and the rest 3 (23%) from fomites.  
Altogether 68 of Pseudomonas aeruginosa isolates were 
obtained from clinical specimens; 31 (45.6%), 20 (29.9%) 
and 17 (27.9%)  were isolated from under 15 yrs, 15-40 
yrs,  above  40  yrs  in  that  order.    In  general  terms,  44 
(64.7%) and 24 (35.3%) isolates were obtained from male 
and female patients respectively.  
  Among  all  positive  isolates  (81),  33  (40.7%)  were 
resistant (<16 mm) to ceftazidime, 26 (32%) amikacin, 20 
(24.7%)  gentamicin  13  (16%)  aztreonam.  Polymyxin  B 
was  uniformly  sensitive  against  all  isolates  (>20  mm). 
Eleven  (13.6%)  multi-drugs  resistant  (MDR) 
Pseudomonas aeruginosa isolates, were recovered from 
clinical  specimens  while  5  (6.2%)  were  recovered  from 
environment  and  hand  impressions.    The  results  of 
prevalence  and  drug  susceptibility  tests  are  shown  in 
Tables 1, 2 and 3. 
 
Table  1:  Prevalence  of  Pseudomonas  aeruginosa  in 
clinical and surveillance samples.  
 
Clinical/Surveillance sites  Swabs  
taken 
Pseudomonas  
aeruginosa isolated 
(%) 
Burn Injuries  80  68 (85.0) 
Hand impression Culture  26  8 (30.8) 
Sinks  10  0 
Floors  5  0 
Walls  12  1 (8.3) 
Door handles  10  2 (20.0) 
Tap water  5  0 
Air culture  10  2 (20.0) 
TOTAL  158  81 (51.3) 
 
Table  2:  In  vitro  susceptibility  of  Pseudomonas 
aeruginosa  isolates  to  commonly  used  antimicrobial 
agents. 
 
Antibiotics (μg)  Number
a (%) of positive Pseudomonas 
aeruginosa isolates 
Sensitive  Intermediate  Resistant 
Amikacin (30)  40 (49%)  14(17.3%)  26(32.1%) 
Aztreonam (10)  54 (55.7%)  14(17.3%)  13 (16%) 
Ceftazidime (10)  29 (35.8%)  19(23.5%)  33 (40.7%) 
Ciprofloxacin (5)  35 (43.2%)  20 (24.7%)  26 (37.1%) 
Gentamicin (10)  49 (60.5%)  12 (14.8%)  20 (24.7%) 
Imipenem (10)  63 (77.8%)  14 (17.3%)  14 (17.5%) 
Meropenem (10)  51 (63.0%)  10 (12.3%)  21(25.9%) 
Piperacillin (100)  30 (37.0%)  22 (27.2%)  28 (34.6%) 
Piperacullin/ 
tazobactam 
(100/10) 
67 (82.7%)  4 (4.9%)  10 (12.3%) 
Polymixynβ 
(300units) 
70 (84.4%)  11 (13.6%)  0 
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Table 3: Antibiotic Resistance Patterns of Pseudomonas 
aeruginosa isolates. 
 
Antibiotics (µg) 
Clinical 
isolates 
 
n = 68, 
R% 
Hand 
culture 
isolates 
n = 8, 
R% 
Environmental 
isolates 
 
n = 5, 
R% 
Amikacin (30)  36  41  20 
Aztreonam (10)  50  49  36 
Ceftazidime (10)  49  35  32 
Ciprofloxacin (5)  40  41  22 
Gentamicin (10)  38  28  30 
Imipenem  (10)  20  16  12 
Meropenem (10)  36  11  18 
Piperacillin (100)  45  26  25 
Piperacullin/ 
tazobactam 
(100/10) 
16  12  15 
Polymixyn β 
(300units) 
0  0  0 
 
DISCUSSION 
 
Pseudomonas aeruginosa isolated from burn injuries have 
significant  effect  on  the  mortality  and  morbidity  in 
hospitalized  burn  patients  particularly  in  a  developing 
country such as ours. Here, we evaluated the colonization 
route  (cross  transmission  mode)  and  drug  susceptibility 
pattern of Pseudomonas aeruginosa in a tertiary burn unit. 
In our study, more male, (73%) and child (57%) patients 
were admitted into the burn unit.  The reason may be a 
combination  of  factors  such  as  male  dominant  activity, 
child  restiveness  and  poor  safety  consciousness  in  our 
society. 
  When  compared  to  other  studies  in  community 
based  hospitals  (Gikas  et  al.,  2002;  Lari  et  al.,  2000), 
nosocomial  infections  of  burn  injuries  carried  by 
Pseudomonas aeruginosa were higher with a prevalence 
of  51.3%  in  the  present  study.  These  differences  are 
partly due to the fact that our facility is largely a referral 
centre with intensive support therapies and hence more 
vulnerable  to  developing  nosocomial  Pseudomonas 
aeruginosa infections. 
  It  also  appears  a  greater  tendency  towards 
increased susceptibility (82%) was evident in combination 
therapeutic  antibacterial  regimen,  particularly  where 
synergy exist (Harris et al., 1999; Rossolini et al., 2005).  
Cross acquisition seems to play an important role in the 
epidemiology of nosocomial colonization of infection with 
Pseudomonas  aeruginosa.    Understanding  the  route  of 
colonization  is  crucial  to  the  development  of  effective 
preventive  measures  against  infection.    Our  findings  of 
15.4% positive environmental isolates highlight the need 
for  further  attention  to  disinfection  of  inanimate  hospital 
environment  and  control  of  contacts  between  staff  and 
patients. Moreover use of some antimicrobial agents must 
be restricted due to existence of high resistance to them. 
  The revelation that 40.7% of isolates were multi-drug 
resistant is not only significant but also instructive. Multi-
drug  resistant  Pseudomonas  aeruginosa  is  quite 
problematic  in  patients  with  burn  injuries  and  may 
illustrate  the  importance  of  selective  pressure  of 
antibiotics.  In  a  study  of  urinary  MDR  P.  aeruginosa 
isolates  in  Jos,  Nigeria,  all  the  100%  isolates  of  P. 
aeruginosa  were  resistant  to  penicillin,  cloxacillin, 
tetracycline,  nitrofurantoin  and  nalidixic  acid  while  67% 
were  sensitive  to  augmentin,  92%  to  ofloxacin,  92%  to 
ciprofloxacin    and  86%    to  cefuroxime  (Jombo  et  al., 
2008). The resistance pattern of P. aeruginosa from urine 
against antibiotics was extremely high. Such a scenario 
will  heighten  the  presence  and  transmission  of  P. 
Aeruginosa from conveniences as well. 
  To  overcome  inappropriate  treatment  of  burn 
patients infected with Pseudomonas, aeruginosa periodic 
antibacterial susceptibility surveys for bacterial isolates in 
burn units are recommended. 
 
CONCLUSION 
 
Pseudomonas  aeruginosa  is  an  opportunistic  pathogen 
with an innate ability to persist during infections due to its 
high  rate  of  resistance  to  many  drugs  including 
ceftazidime,  ciprofloxacin,  piperacillin,  imipenem, 
pipereracillin/tazobactam  and  aztreonam.    These 
antibiotics  are  top  of  the  range  first  line  therapy 
candidates for bacteria – associated infections. Evidence 
of  high  prevalence  of  clinical  and  environmental  MRPA 
reported in this study and their apparent resistant patterns 
observed provides the rationale for strict enforcement of 
infection  prevention  protocol  to  minimize  cross 
transmission of bacterial pathogens in hospital burn units 
and consequent disease burden arising from MRPA. 
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